Tokorozawa, Japan

Masayuki Shinmei

This inventor holds 1 USPTO granted patent. Top assignee: Tetjin Limited. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayuki Shinmei. Retrieved from https://idiyas.com/inventor/masayuki-shinmei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masayuki Shinmei: Innovator in Chondrocalcin Determination

Introduction

Masayuki Shinmei is a notable inventor based in Tokorozawa, Japan. He has made significant contributions to the field of immunoassays, particularly in the determination of chondrocalcin. His work is essential for diagnosing cartilage-related diseases in mammals.

Latest Patents

Masayuki Shinmei holds a patent for a method for determining chondrocalcin. This innovative method utilizes an enzyme-labeled mammalian chondrocalcin or enzyme-labeled anti-chondrocalcin antibody. The process is characterized by the use of mammalian body fluid as a specimen, allowing for immunoreaction in a solution to determine chondrocalcin levels. This determination can be utilized for diagnosis or related applications in mammals.

Career Highlights

Shinmei is associated with Tetjin Limited, where he applies his expertise in immunoassays. His work has garnered attention for its potential impact on medical diagnostics and treatment strategies.

Collaborations

Some of his notable coworkers include Ryoichi Hasegawa and Kenji Hosoda. Their collaboration has contributed to advancements in the field of immunoassays and related research.

Conclusion

Masayuki Shinmei's innovative approach to determining chondrocalcin represents a significant advancement in medical diagnostics. His contributions are vital for understanding and diagnosing cartilage-related diseases in mammals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…